Arcellx (ACLX) Assets (2021 - 2025)
Arcellx's quarterly Assets came in at $604.0 million in Q4 2025, down 15.09% year-on-year from $711.3 million in Q4 2024, and down 7.92% quarter-over-quarter from $655.9 million in Q3 2025.
Arcellx has reported Assets for 5 years, with the latest figure at $604.0 million in Q4 2025.
- For the quarter ending Q4 2025, Assets fell 15.09% year-over-year to $604.0 million; the trailing twelve-month figure through Dec 2025 stood at $604.0 million (down 15.09% YoY), and the FY2025 full-year result was $604.0 million, down 15.09% from the prior year.
- Assets for Q4 2025 stood at $604.0 million, down from $655.9 million in the prior quarter.
- The five-year high for Assets was $825.1 million in Q4 2023, with the low at $128.8 million in Q4 2021.
- Average Assets over 5 years is $565.0 million, with a median of $622.9 million recorded in 2023.
- Year-over-year, Assets jumped 162.93% in 2023 and declined 16.88% in 2025.
- Tracing ACLX's Assets over 5 years: stood at $128.8 million in 2021, then jumped by 143.68% to $313.8 million in 2022, then jumped by 162.93% to $825.1 million in 2023, then retreated by 13.79% to $711.3 million in 2024, then dropped by 15.09% to $604.0 million in 2025.
- The last three Assets figures came in at $604.0 million (Q4 2025), $655.9 million (Q3 2025), and $619.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 603.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 603.99 Mn |
| Sep 30, 2025 | 655.92 Mn |
| Jun 30, 2025 | 619.09 Mn |
| Mar 31, 2025 | 648.08 Mn |
| Dec 31, 2024 | 711.33 Mn |
| Sep 30, 2024 | 764.91 Mn |
| Jun 30, 2024 | 734.31 Mn |
| Mar 31, 2024 | 779.70 Mn |
| Dec 31, 2023 | 825.13 Mn |
| Sep 30, 2023 | 614.22 Mn |
| Jun 30, 2023 | 623.53 Mn |
| Mar 31, 2023 | 622.94 Mn |
| Dec 31, 2022 | 313.82 Mn |
| Sep 30, 2022 | 337.33 Mn |
| Jun 30, 2022 | 374.66 Mn |
| Mar 31, 2022 | 246.98 Mn |
| Dec 31, 2021 | 128.78 Mn |